Beyond Pathological Calcification - PowerPoint PPT Presentation

1 / 44
About This Presentation
Title:

Beyond Pathological Calcification

Description:

Beyond Pathological Calcification: Strategies for Coping with the Effects of Glycation, Oxidation and Inflammation on Cellular Aging Factors Affecting Aging Chronic ... – PowerPoint PPT presentation

Number of Views:216
Avg rating:3.0/5.0
Slides: 45
Provided by: trinitycl9
Category:

less

Transcript and Presenter's Notes

Title: Beyond Pathological Calcification


1
Beyond Pathological Calcification
  • Strategies for Coping with the Effects of
    Glycation, Oxidation and Inflammation on Cellular
    Aging

2
David B. Wood, ND BSc. Univ of WA
(Microbiology) 1977 ND. Bastyr Univ.
1983 Cofounder, Vice President,
CMO BioGenesis Nutraceuticals, Inc.(2000 - )
Cofounder, President Trinity Family
Health Clinic, PS (1984 - ) Functional
Medicine Forum - 2006
3
Factors Affecting Aging
  • Chronic Inflammation
  • Excess or pathological Calcification
  • Glycation
  • Methylation Deficit
  • Mitochondrial Energy Depletion
  • Hormone Imbalance
  • Fatty Acid Imbalance

4
  • DNA Mutation
  • Immune Dysfunction
  • Non-Digestive Enzyme Imbalance (intracellular)
  • Digestive Enzyme Deficit
  • Excitotoxicity
  • Circulatory Deficit
  • Oxidative Stress

5
In this lecture I will discuss how specific
nutraceutical interventions can help offset the
aging effects of glycation (AGEs) and its
concomitant effects on oxidation and inflammation
on our cellular structure, glands and
organs. Benefits positively affecting health,
vitality and longevity can be achieved with a
healthy lifestyle (diet, nutrition, exercise,
stress reduction) and specific nutraceutical
intervention .
6
(No Transcript)
7
  • Advanced Glycation Endproducts (AGE)
  • When proteins are exposed to elevated levels of
    glucose the following series of non-enzymatic
    chemical reactions occur
  • Glycation of proteins and formation of both
    Amadori adducts and AGE compounds can have
    biological consequences
  • Glycation Rearrangement
    Cross-linking
  • hours days
    weeks/months
  • Glucose Glycated Amadori
    proteins
    Adducts AGES
  • Protein-NH2 (Schiff Base)
  • Cell Activation
  • Tissue Structural Changes

8
Glycation
  • Occurs in everyone, but at a faster rate in
    diabetics
  • Has devastating effects on the health of our
    tissues
  • Most evident in
  • Senile dementia
  • Stiffening of the arterial system
  • Degenerative diseases of the eye

9
Some outward examples of AGEs
Not us!
10
Negative Aspects of AGEs
Good News! When added to living cell cultures,
carnosine extends their life span. When added to
decrepit aged cells, it rejuvenates them.
11
AGEx (Advanced Glycation Endproduct inhibitor)
Each 4 capsules contain L-Carnosine
1000mg Galega officinalis (50 guanidine with
negligible content of galegine) 500mg L-Arginine
300mg DMAE (dimethylaminoethanol) 300mg Ascor
bic acid 100mg PABA (para aminobenzoic
acid) 100mg Vit E (d-alpha tocopheryl
succinate) 200IU Thiamine HCl
50mg Alpha R Lipoic acid 50mg Pyridoxal 5
phosphate 35 mg Take 2 capsules two
times per day without food or as directed.
RecommendationTake AGEx with Glucostat
multivitamin/mineral and a diet made with low
glycemic functional foods and dietary
foods. 120ct
12
L-Carnosine (B-alanyl-L-histidine)
  • Naturally occurring di-peptide
  • Found in muscle, brain, innervated tissues, lens
    and other tissues
  • Powerful antioxidant
  • Singlet oxygen, hydrogen peroxide, peroxyl and
    hydroxyl radicals
  • Inhibits free radical induced damage from iron,
    copper and zinc
  • Powerful anti-glycation agent
  • Activates myofibillar ATPase enhancing muscle
    contractions

13
  • Increases cellular energy by enhancing
    mitochondrial oxidative energy production (ATP)
  • Average dietary intake 50 250 mg from one
    serving of beef, pork or chicken (3-4 ounces)
  • Therapeutic intake (supplemental)
  • 1000 mg QD
  • Protects SOD from oxidation
  • Prevents accumulation of age-related free
    radicals

14
L-Carnosine (B-alanyl-L-histidine)
  • May protect against oxidative stress associated
    w/Alzheimers Dz
  • Protects neuronal and endothelial cells from
    damage
  • Has anti-glycating properties
  • Improves memory in Alzheimers
  • Improves cognition in Alzheimers
  • Protects against malondialdehyde toxicity
  • Provides protection to cells and molecules from
    free radical damage

15
  • Delays aging in human cells
  • Protects against toxic aldehydes. Thus offers
    protection from diabetes complications,
    inflammatory ailments, and ETOH related liver
    disease
  • Positive affect on healthy protein metabolism
  • Positive affect on cellular homeostasis
  • Prevents development of senility features
  • Aids in wound healing (Its degradation product,
    B-Alanine, enhances collagen production)

16
  • Enhances the immune system
  • Reduces lactic acid accumulation
  • Promotes muscle recovery, enhancing athletic
    performance
  • Anti-hypertensive effects
  • Reduces lipid peroxide production and inhibits
    LDL C oxidation
  • Source - Life Extension Carnosine overview
  • www.lef.org

17
Impaired reverse cholesterol transport
Facilitation of oxidation
Toxicity to endothelium
Impaired esterbation of cholesterol
18
Calcification often accompanies glycation!
Nanobacteria, C. Pneumoniae
Chicken or Egg?
19
L-Carnosine (B-alanyl-L-histidine)
  • Stvolinskii SL, Fedorova TN, Yuneva MO, Boldyrev
    AA. Protective effect of carnosine on Cu,
    Zn-superoxide dismutase during impaired oxidative
    metabolism in the brain in vivo. Institute of
    Neurology, Russian Academy of Medical Sciences,
    Moscow. Bull Exp Biol Med. 2003
    Feb135(2)130-2.
  • Dukic-Stefanovic S, Schinzel R, Riederer P, Munch
    G. AGES in brain aging AGE-inhibitors as
    neuroprotective and anti-dementia drugs?
    Pysiological Chemistry 1, Biocenter, Univ of
    Wurzberg, Germany. Biogerontology
    20012(1)19-34.
  • Forster MJ, Dubey A, Dawson KM, Stutts WA, Lal H,
    Sohal RS. Age-related losses of cognitive
    function and motor skills in mice are associated
    with oxidative protein damage in the brain.
    Dept. of Pharmacology, Univ. of N. Texas Health
    Science Center, Fort Worth, TX. Proc Natl Acad
    Scid. 1996 May 1493(10)4765-9.

20
  • Gulyaeva NV, Dupin AM, Levshina IP. Carnosine
    prevents activation of free-radical lipid
    peroxidation during stress. Bull Exp Biol Med.
    1989 107(2)148-152.
  • Horning MS, Blakemore LJ, Trombley PQ.
    Endogenous mechanisms of neuroprotection role of
    zinc, copper, and carnosine. Brain Res 2000 Jan
    3852(1)56-61.
  • Our results demonstrate that carnosine can
    rescue neurons from zinc- and copper-medicated
    neurotoxicity and suggest that one function of
    carnosine may be as an endogenous neuroprotective
    agent
  • Boldyrev A, Song R, Lawrence D, Carpenter DO.
    Carnosine protects against excitotoxic cell death
    independently of effects on reactive oxygen
    species. Neuroscience. 199994(2)571-7.

21
Pluripotent protective effects of carnosine, a
naturally occurring dipeptide
  • Selected quotes from this study
  • Evidence will be presented to suggest that
    carnosine, in addition to antioxidant and oxygen
    free-radical scavenging activities, also reacts
    with deleterious aldehydes to protect susceptible
    macromolecules. Our studies show that, in vitro,
    carnosine inhibits nonenzymic glycosylation and
    cross-linking of proteins induced by reactive
    aldehydes (aldose and ketose sugars, certain
    triose glycolytic intermediates and
    malondialdehyde (MDA), a lipid peroxidation
    product).

22
Hipkiss AR, Preston JE, Himsworth DT, Worthington
VC, Keown M, Michaelis J, Lawrence J, Mateen A,
Allende L, Eagles PA, Abbott NJ. Pluripotent
protective effects of carnosine, a naturally
occurring dipeptide. Ann NY Acad Sci. 1998 Nov
2085437-53.
  • We propose that carnosine (which is remarkably
    nontoxic) or related structures should be
    explored for possible intervention in pathologies
    that involve deleterious aldehydes, for example
    secondary diabetic complications, inflammatory
    phenomena, alcoholic liver disease, and possibly
    Alzheimers disease.

23
  • Sztanke K, Pasternak K. The Maillard reaction
    and its consequences for a living body. Ann Univ
    Mariae Curie Sklodowska Med 200358(2)159-162.
  • Wautier JL, Schmidt AM. Protein glycation a
    firm link to endothelial cell dysfunction. Circ
    Res. 2004 Aug 695(3)233-8.
  • Loeser RF, Jr. Aging cartilage and
    osteoarthritis whats the link? Sci Aging
    Knowledge Environ. 2004 Jul 212004(29)e31.
  • Seidler NW, Yeargans GS, Morgan TG. Carnosine
    disaggregates glycated alpha-crystallin an in
    vitro study. Arch Biochem Biophys. 2004 Jul
    1427(1)110-15.
  • Dukic-Stefanovic S, Schinzel R, Riederer P, Munch
    G. AGES in brain ageing AGE- inhibitors as
    neuroprotective and antidementia drugs?
    Biogerontology. 20012(1)19-34.

Betty Crocker Slow-Cook Oven
24
Beyond Carnosine
  • Compounds that Inhibit Sugar attachment to
    Protein (Glycation)
  • Pyridoxal 5 phosphate
  • ASA (Aspirin)
  • Compounds that Inhibit or Block formation of
    Crosslinks
  • Guanidine (Goats Rue Galega officinalis)
  • Aminoguanidine
  • Compounds that Trap reactive Carbonyl
    Intermediates
  • (CO compounds lead to AGEs)
  • Guanidine(Galega)/Aminoguanidine, Carnosine,
    L-Arginine

25
  • Chelating Agents that inhibit conversion of
    Schiff Bases to Amadori Products
  • EDTA (Liposomal oral EDTA, rectal suppository or
    IV)
  • Penicillamine
  • Antioxidant Agents that inhibit conversion of
    Schiff Bases to Amadori Products
  • Vitamin C
  • Vitamin E
  • Lipoic Acid

26
  • Botanical Antioxidants that may inhibit
    conversion of Schiff Bases to Amadori products
  • Green Tea, Hawthorn, Grape Seed, Milk Thistle,
    Ginger Root, Ginkgo
  • Aboca provides these botanicals as organic cold
    processed, freeze-dried whole phytocomplex
    concentrates!
  • Compounds that Inhibit formation of Amadori
    Products
  • Guanidine (Galega)/Aminoguanidine

27
EDTA Penicillamine Vit C, E, ARLA
Galega Guanidine Aminoguanidine
Glucose Glycated Amadori
proteins
Adducts AGES Protein-NH2 (Schiff Base)
Pyridoxal 5 Phosphate Aspirin
Reactive Intermediates CO
Galega Guanidine Aminoguanidine Carnosine L-Argini
ne
Galega Guanidine Aminoguanidine
28
Pyridoxal 5 phosphate
  • Bioactive form of Vitamin B6
  • Significantly reduces non-enzymatic glycation of
    proteins
  • Inhibits AGE formation
  • Exceeded only by aminoguanidine

29
Thiamine
  • Vitamin B1 or thiamine is the parent compound for
    the development of a promising new compound
    ALT-711.
  • This compound shows promise in being able to
    UNDUE existing crosslinked proteins.
  • Thiamine is an effective crosslink breaker
    (Pearson and Shaw)
  • Breaking existing crosslinks has been shown to
    improve arterial elasticity.

30
Galega officinalis (Goats Rue)
  • Historical use for Diabetic treatment for
    centuries
  • Contains Guanidine which results in its
    glucose/insulin regulating properties
  • Insulin sensitizing, glucose lowering
  • Safe Galega should have negligible content of
    galegine. Galegine may cause nasal discharge and
    blood pressure lowering.
  • Metformin (Glucophage) antidiabetic biguanide
    derived from Galega officinalis.

31
Alpha R-Lipoic Acid
  • Strong antioxidant protection and enhanced
    antioxidant recycling
  • Enhanced biological energy production
  • Fat and water soluble
  • Natural form
  • Claims that lipoic acid slows aging of the brain
    and has anti-aging benefits seem to be related to
    is potent antioxidant properties
  • Reduces production of Amadori adducts
  • Packer L, Tritschler HJ, Wessel K.
    Neuroprotection by the metabolic antioxidant
    alpha-lipoic acid. Free Rad Biol Med. 1997
    22359-378.

32
Antioxidants and Neuroprotection
  • Vitamin E
  • Alpha R Lipoic Acid
  • Coenzyme Co Q10

Antioxidants reduce formation of Amadori adducts
33
Vitamin E and Cognitive Decline in Older Persons
  • There was a 36 reduction in the rate of decline
    among persons in the highest quintile of total
    vitamin E intake (-4.3 x 10(-2) standardized
    units per year) compared with those in the lowest
    quintile (-6.7 x 10(-2) standardized units per
    year) (P .05), in a model adjusted for age,
    race, sex, educational level, current smoking,
    alcohol consumption, total calorie (energy)
    intake, and total intakes of vitamin C, carotene,
    and vitamin A. We also observed a reduced decline
    with higher vitamin E intake from foods (P .03
    for trend). There was little evidence of
    association with vitamin C or carotene intake.
  • CONCLUSION Vitamin E intake, from foods or
    supplements, is associated with less cognitive
    decline with age.
  • Arch Neurol 2002 Jul59(7)1125-32

34
DMAEDimethyl amino ethinol
  • Alleviates behavioral problems and hyperactivity
    associated with Attention Deficit Disorder (ADD)
  • Made naturally in the brain
  • Increases attention span
  • Decreases aggression
  • Improves learning ability
  • Occassionally shows increase in IQ (70 of ADD
    patients)

35
DMAE
  • Inhibits and reverses cross-linking of proteins
  • Facilitates removal of lipofuscin from neurons
    and skin (age spots)
  • Increases alertness
  • Alleviates anxiety
  • Reduces apathy and increases motivation
  • Improves interhemispheric flow of information in
    the corpus callosum thereby improving creativity
    and verbal fluency
  • Improves behavior and mental function in Downs
    syndrome children

36
DMAE
  • Improves memory and learning
  • Elevates mood
  • Reduces sleep need by 1 hour after 6 weeks of
    use
  • Dreams become more lucid (vivid)
  • Sleep is sounder with clearer head on waking and
    more refreshed
  • Enhances Acetylcholine levels within the brain
  • Increases RNA in the brain (rat research)
  • Increases Choline levels within the brain due to
    DMAEs superior ability to cross the Blood-Brain
    Barrier

37
DMAE
  • References
  • Coleman N, et al. DMAE in the treatment of
    hyperactive children. Psychosomatics 1768-72,
    1976.
  • Oettinger L. The use of DMAE in the treatment of
    disorders of behavior in children. J Pediatrics.
    53671-675, 1958.
  • Cedar G, et al. Effects of 2-Dimethylaminoethanol
    (DMAE) on the metabolism of choline in plasma.
    J Neurochemistry. 301293-1296, 1978.
  • Zs-Nagy, I, et al. On the role of cross-linking
    of cellular proteins in aging. Mech Agi Dev.
    14245-251, 1980.
  • Hochschile R. Effect of dimethylaminoethanol on
    the life span of senile male A/J mice. Exp
    Gerontol, 1973, 8 4, 185-191.

38
  • Also present in

39
PABA (para amino benzoic acid)
  • Antioxidant
  • Quenches singlet oxygen
  • Provides protection against
  • Ozone
  • Smoking
  • Other air pollutants
  • Anti-Crosslinking Agent
  • Appears to slow or reverse crosslinking in
    protein connective tissue structures (ie.
    Collagen)

40
PABA
  • Anti-Aging
  • Promotes greater flexibility
  • Useful in Tx of vitiligo (a depigmenting disease)
  • Helps prevent graying of hair or restore normal
    hair color in 10-25 of patients
  • Reduces fibrotic processes
  • Peyronnies disease
  • Dupuytrens contracture
  • Scleroderma

41
Some PABA references
  • Zarafonetis C. Darkening of gray hair during
    para-amino-benzoic acid therapy. J Invest Derm,
    399-401.
  • Allen JM. Rapid Reaction of Singlet Oxygen with
    P-Aminobenzoic Acid (PABA) in Aqueous Solution.
    Biochem Biophys Res Commun, July 1995.
  • Bjorksten J. Crosslinkage and the aging process,
    in Theoretical Aspects of Aging, by Morris
    Rockstein (ed), Academic Press, NY, 1974.
  • Zarafonetis C. Antifibrotic Therapy with POTABA.
    Am J of Med Sci, 1964, 248550-561
  • Dean W. DMAE and PABA, An Alternative to
    Gerovital (GH3), the Romanian Youth Drug. Vit
    Res Prod. (vrp.com)

42
Additional References
  • Carpenter D. Correction of biological aging.
    Rejuvenation, 1980,731-49
  • Bjorksten J. Possibilities and limitations of
    chelation as a means for life extension.
    Rejuvenation, 1980, 867-72.
  • Zinsser J, Butt EM, Leonard I. Metal content
    correlation in aging aorta. J Am Geriatrics Soc,
    1957, 520-26.
  • Chappell LT, Stahl JP, Evans R. EDTA Chelation
    treatment for vascular disease A Meta-Analysis
    using unpublished data. J Adv Med, 1994, 7 3,
    131-142.

43
BioGenesis products to consider for Anti-Aging
  • AGEx
  • Liposomal EDTA
  • CogniFactors
  • Aboca botanicals Green Tea, Hawthorn, Grape
    Seed, Milk Thistle, Ginger Root, Ginkgo
  • Vitamin E, Alpha R Lipoic Acid, Coenzyme CoQ10,
    Seleno ExCell, Oxy ATP, Cardio Complete, High
    ORAC Berry Blend

44
Contacts for Dr. David Wood dwoodnd_at_bio-genesis.co
m dwoodnd_at_trinityclinic.com
May your practices and your patients be blessed
by your care
Write a Comment
User Comments (0)
About PowerShow.com